High-dose bevacizumab improves survival when combined with FOLFOX4 in previously treated advanced colorectal cancer: Results from the Eastern Cooperative Oncology Group (ECOG) study E3200
暂无分享,去创建一个
P. Catalano | A. Benson | S. Alberts | P. O'dwyer | N. Meropol | E. Mitchell | B. Giantonio | M. Schwartz